1. Home
  2. VYGR vs ELMD Comparison

VYGR vs ELMD Comparison

Compare VYGR & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.00

Market Cap

232.4M

Sector

Health Care

ML Signal

HOLD

Logo Electromed Inc.

ELMD

Electromed Inc.

HOLD

Current Price

$28.41

Market Cap

232.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
ELMD
Founded
2013
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
232.4M
232.0M
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
VYGR
ELMD
Price
$4.00
$28.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$17.00
$36.00
AVG Volume (30 Days)
467.1K
46.8K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.89
EPS
N/A
0.94
Revenue
$31,316,000.00
$66,218,999.00
Revenue This Year
N/A
$14.63
Revenue Next Year
$71.78
$11.54
P/E Ratio
N/A
$31.83
Revenue Growth
N/A
16.05
52 Week Low
$2.65
$17.73
52 Week High
$6.37
$35.56

Technical Indicators

Market Signals
Indicator
VYGR
ELMD
Relative Strength Index (RSI) 40.94 59.36
Support Level $4.24 $29.45
Resistance Level $4.58 $30.49
Average True Range (ATR) 0.24 0.97
MACD -0.01 0.02
Stochastic Oscillator 31.36 58.07

Price Performance

Historical Comparison
VYGR
ELMD

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Share on Social Networks: